Filing Details

Accession Number:
0000899243-20-000793
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-07 19:39:22
Reporting Period:
2020-01-06
Accepted Time:
2020-01-07 19:39:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-06 12,687 $68.45 96,777 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 225,947 Indirect By Reporting Person's Trust 2
Common Stock 323,526 Indirect By Reporting Person's Trust 3
Common Stock 12,200 Indirect By Trust 1
Common Stock 12,200 Indirect By Trust 2
Common Stock 12,200 Indirect By Trust 3
Footnotes
  1. Shares sold to cover withholding taxes in connection with vesting of Restricted Stock Units reported on Form 4 filed by the Reporting Person on January 3, 2020.
  2. Represents the weighted average sale price of the shares sold ranging from $68.35 to $68.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.